Literature DB >> 176361

Genetic factors in amyloidosis.

P K Thomas.   

Abstract

In the absence of biochemical distinctions, the nosography of the inherited amyloidoses must at present depend largely upon clinical subdivisions. In the broad classification adopted here, the disorders have for convenience been grouped according to the anatomical system that is predominantly affected. It is evident that the amyloid syndromes display considerable heterogeneity. However, they overlap. Thus in the Iowa type classified with the hereditary amyloid neuropathies (van Allen et al, 1969; Gimeno et al, 1974), renal involvement was frequent and was the usual cause of death. In the English (Zalin et al, 1974) and Scandinavian (Andersson, 1970) families with neuropathy as the predominant feature, cardiac involvement was a common finding. In certain of the conditions discussed, such as medullary carcinoma of the thyroid and Down's syndrome, amyloid deposition is merely an incidental aspect of the disorder. In those conditions in which generalized or localized amyloid deposition occupies a more central position in the clinical syndrome, an autosomal dominant inheritance has been established or suggested in the majority. An autosomal recessive inheritance has so far only been recognized in familial Mediterranean fever. In the family with hereditary amyloid heart diseases reported by Fredricksen et al (1962), the disorder was confined to a single sibship, raising the possibility of recessive inheritance. This could also be true in sporadic examples of primary amyloidosis. The dominantly inherited amyloidoses comprise a number of geographically widely scattered families with clinical pictures that do not show consistent differences between some families. The families that do not show consistent differences are not necessarily harbouring nutations at the same locus, or the same mutation at any particular locus. However, many of these dominantly inherited clinical syndromes are sufficiently different from each other and the clinical manifestations of each sufficiently consistent to indicate that separate main genes are likely to be involved...

Entities:  

Mesh:

Year:  1975        PMID: 176361      PMCID: PMC1013309          DOI: 10.1136/jmg.12.4.317

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  75 in total

1.  Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. An immuno-histochemical, light-microscopical and electron-microscopical study.

Authors:  J Meretoja; E J Jokinen; Y Collan; J Lähdevirta
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1972

2.  Peripheral nerve changes in amyloid neuropathy.

Authors:  P K Thomas; R H King
Journal:  Brain       Date:  1974-06       Impact factor: 13.501

3.  Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes.

Authors:  A Coimbra; C Andrade
Journal:  Brain       Date:  1971       Impact factor: 13.501

4.  Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes.

Authors:  A Coimbra; C Andrade
Journal:  Brain       Date:  1971       Impact factor: 13.501

5.  Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.

Authors:  A L Steiner; A D Goodman; S R Powers
Journal:  Medicine (Baltimore)       Date:  1968-09       Impact factor: 1.889

6.  Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer.

Authors:  M W Van Allen; J A Frohlich; J R Davis
Journal:  Neurology       Date:  1969-01       Impact factor: 9.910

7.  Portuguese type of familial amyloid polyneuropathy. Anatomo-clinical study of a Brazilian family.

Authors:  O F Julião; L S Queiroz; J Lopes de Faria
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

8.  Amyloidotic polyneuritis of type 3 (Iowa-Van Allen).

Authors:  A Gimeno; C Garcia-Alix; J M Segovia de Arana; F Mateos; M T Sotelo
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

9.  Hereditary cerebral haemorrhage with amyloidosis.

Authors:  G Gudmundsson; J Hallgrímsson; T A Jónasson; O Bjarnason
Journal:  Brain       Date:  1972       Impact factor: 13.501

10.  Primary neuropathic amyloidosis in three brothers.

Authors:  A Zalin; A Darby; S Vaughan; E B Raftery
Journal:  Br Med J       Date:  1974-01-12
View more
  4 in total

1.  Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.

Authors:  G Boysen; G Galassi; Z Kamieniecka; J Schlaeger; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

2.  A father and his son with systemic AL amyloidosis.

Authors:  Stina Enqvist; Ulf-Henrik Mellqvist; Johan Mölne; Knut Sletten; Charles Murphy; Alan Solomon; Fred J Stevens; Per Westermark
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

Review 3.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

4.  What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?

Authors:  Robyn A Wallace; Arthur J Dalton
Journal:  Alzheimers Res Ther       Date:  2011-04-19       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.